Authors: Diaz, BG Gross, S Assfalg-Machleidt, I Pfeiler, D Gollmitzer, N Gabrijelcic-Geiger, D Stubbs, MT Fritz, H Auerswald, EA Machledit, W

Citation: Bg. Diaz et al., Cystatins as calpain inhibitors: Engineered chicken cystatin- and stefin B-kininogen domain 2 hybrids support a cystatin-like mode of interaction with the catalytic subunit of mu-calpain, BIOL CHEM, 382(1), 2001, pp. 97-107

Authors: Koiwa, H D'Urzo, MP Assfalg-Machleidt, I Zhu-Salzman, K Shade, RE An, HJ Murdock, LL Machleidt, W Bressan, RA Hasegawa, PM

Citation: H. Koiwa et al., Phage display selection of hairpin loop soyacystatin variants that mediatehigh affinity inhibition of a cysteine proteinase, PLANT J, 27(5), 2001, pp. 383-391

Authors: Schaschke, N Assfalg-Machleidt, I Machleidt, W Lassleben, T Sommerhoff, CP Moroder, L

Citation: N. Schaschke et al., beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells, BIOORG MED, 10(7), 2000, pp. 677-680

Authors: Muehlenweg, B Assfalg-Machleidt, I Parrado, SG Burgle, M Creutzburg, S Schmitt, M Auerswald, EA Machleidt, W Magdolen, V

Citation: B. Muehlenweg et al., A novel type of bifunctional inhibitor directed against proteolytic activity and receptor/ligand interaction - Cystatin with a urokinase receptor binding site, J BIOL CHEM, 275(43), 2000, pp. 33562-33566

Authors: Schaschke, N Assfalg-Machleidt, I Lassleben, T Sommerhoff, CP Moroder, L Machleidt, W

Citation: N. Schaschke et al., Epoxysuccinyl peptide-derived affinity labels for cathepsin B, FEBS LETTER, 482(1-2), 2000, pp. 91-96

Authors: Randak, C Auerswald, EA Assfalg-Machleidt, I Reenstra, WW Machleidt, W

Citation: C. Randak et al., Inhibition of ATPase, GTPase and adenylate kinase activities of the secondnucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein, BIOCHEM J, 340, 1999, pp. 227-235